Andropenis

Andropenis is a medical-grade penile traction device invented in 1996 by Dr. Eduardo Gómez de Diego. FDA registered and CE marked, Andropenis delivers clinically proven penis enlargement and Peyronie's disease treatment through patented traction technology.

The Science of Penile Traction

Dr. Eduardo Gómez de Diego pioneered penile traction therapy after discovering that a third of patients at his men's health clinic sought solutions for penis size concerns. Investigating medical techniques including bone traction and skin tissue development, he created the first penile traction device capable of achieving permanent enlargement without surgery. Published clinical studies in the British Journal of Urology International and Journal of Sexual Medicine confirm the efficacy and safety of Andropenis devices. The American Urological Association and European Association of Urology now recommend penile traction devices as remodeling techniques for treating Peyronie's disease penile curvature.

• Founded: 1996 by Dr. Eduardo Gómez de Diego, Madrid, Spain.
• Company: Andromedical S.L. (Spain) and Andromedical LLC (USA).
• Recognition: 7,000+ urologists worldwide recommend Andromedical devices.

Clinically Proven Results

Multiple independent clinical studies validate Andropenis effectiveness. The landmark 2008 University of Turin study published in British Journal of Urology International concluded that penile extenders should be regarded as minimally invasive and effective treatment options for elongating the penile shaft. Research demonstrates average length increases of 4cm (1.6 inches) and girth increases of 1.5cm (0.6 inches) with consistent use. The average growth rate equals approximately 0.5cm per month during a 3-6 month treatment period. Results are permanent because traction therapy stimulates cellular multiplication in penile tissue—the same biological principle used in bone lengthening and skin expansion medical procedures.

Andropenis Pro

The Andropenis Pro provides the core traction system for penile enlargement therapy. Designed for penises longer than 10cm in erect length, the device applies calibrated traction force between 600-1,500 grams to stimulate tissue growth safely. Worn 4-9 hours daily on the flaccid penis, the extender accommodates walking, sitting, and standing activities discreetly under clothing. The kit includes the traction device, 20 extension rods for progressive lengthening, comfort bands, protective tubes, and detailed instructions. Medical-grade materials ensure biocompatibility and safety during extended wear.

Andropenis Gold

The premium Andropenis Gold features 24-karat gold covering for enhanced aesthetics and durability. This luxury version includes all components of the Pro system plus a travel bag for discreet storage. The gold plating provides hypoallergenic properties while adding prestige to the treatment experience. Same clinically proven traction technology with elevated presentation for those seeking the finest medical devices.

Andropenis Mini

Specifically engineered for micropenis treatment where erect length measures under 10cm, Andropenis Mini addresses unique sizing requirements. The compact frame accommodates smaller anatomy while delivering the same effective traction therapy. Includes Androsupport accessories for optimal positioning and comfort during treatment. Clinical studies with hypogonadism patients using Andropenis alongside hormonal therapy achieved average length increases of 6.5cm in erection.

Andropeyronie

Andropeyronie treats Peyronie's disease penile curvature using targeted traction therapy. Clinical evidence demonstrates 60% reduction in penile curvature with consistent use. The device includes specialized Androsupport components designed to address all types of penile curvatures—dorsal, ventral, and lateral deviations. The American Urological Association and Canadian Urology Association recommend penile traction devices as conservative treatment before considering surgical intervention. Featured in The New York Times coverage of new Peyronie's disease treatments.

Androsurgery

Developed for post-operative rehabilitation following prostate surgery, penile implant procedures, or other urological surgeries that may cause penile shortening. Androsurgery includes dual Androsupport accessories for secure positioning on healing tissue. Urologists prescribe traction devices to prevent penile retraction and maintain length gains achieved through surgery. The surgical extender follows the same proven traction principles adapted for sensitive post-operative care.

Product Guide

Key Features

• FDA registered and CE marked medical devices with ISO 13485 quality certification.
• Invented 1996 by Dr. Eduardo Gómez de Diego—patent holder of penile traction technology.
• Published clinical studies in British Journal of Urology International and Journal of Sexual Medicine.
• Recommended by American Urological Association and European Association of Urology.
• Average results: 4cm length increase, 1.5cm girth increase, 60% curvature reduction.
• Biocompatibility tested medical-grade materials safe for extended daily wear.
• Over 1 million satisfied users and 7,000+ recommending urologists worldwide.
• Featured in Men's Health, New York Times, TIME, Cosmopolitan, and The Guardian.
• Discreet wear under clothing while walking, sitting, or standing—4-9 hours daily use.
• Permanent results through natural cellular tissue growth—no surgery required.

Discover how Andropenis penile traction technology can address size concerns and Peyronie's disease with clinically proven, FDA registered medical devices. Read our exclusive interview with Dr. Eduardo Gómez de Diego for insights from the inventor of penile traction therapy.